PUT - SPRINTER OPEN END - BIOGEN IDEC | Delayed Deutsche Boerse AG 11:03:23 2024-06-27 EDT | ||
| 12.99 EUR | -4.84% |
|
| Current month | +3.10% | ||
| 1 month | -1.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 12.99 | -4.84% |
| 24-06-26 | 13.65 | +1.19% |
| 24-06-25 | 13.49 | +2.04% |
| 24-06-24 | 13.22 | -2.36% |
| 24-06-21 | 13.54 | +1.96% |
Delayed Quote Deutsche Boerse AG
Last update June 27, 2024 at 11:03 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VQ9GKN |
| ISIN | DE000VQ9GKN4 |
| Date issued | 2021-07-12 |
| Strike | 366 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.12 € |
|---|---|
| Lowest since issue | 1.41 € |
| Spread | 0.03 € |
| Spread % | 0.23% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
224.5
USD
Average target price
283.2
USD
Spread / Average Target
+26.15%
- Stock Market
- Certificates
- Certificat
